老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

51.72
-0.5400-1.03%
盤後：51.800.0800+0.15%19:47 EDT
成交量：85.67萬
成交額：4,464.35萬
市值：50.01億
市盈率：-10.87
高：53.21
開：52.35
低：51.62
收：52.26
52周最高：78.48
52周最低：44.12
股本：9,669.26萬
流通股本：9,316.62萬
量比：0.69
換手率：0.92%
股息：- -
股息率：- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
淨資產收益率：-26.09%
總資產收益率：-14.20%
市淨率：2.86
市盈率(LYR):-7.99

資料載入中...

總覽公司新聞公告
2020/05/14

重要事件披露

8-K - Current report
2020/05/11

重要事件披露

Current report, items 7.01 and 9.01
2020/04/28

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/04/28

重要事件披露

Current report, items 2.02 and 9.01
2020/03/31

重要事件披露

Current report, item 8.01
2020/02/26

重要事件披露

8-K - Current report
2020/02/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/29

重要事件披露

Current report, item 5.02
2020/01/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

重要事件披露

Current report, items 1.02, 5.02, and 9.01
2019/12/16

重要事件披露

Current report, items 1.01, 1.02, and 2.01
2019/11/26

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/22

重要事件披露

Current report, items 1.01, 8.01, and 9.01
更多